Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Feb;37(1):e14532.
doi: 10.1111/1742-6723.14532. Epub 2024 Nov 18.

Review article: Primer for clinical researchers on innovative trial designs for emergency medicine

Affiliations
Review

Review article: Primer for clinical researchers on innovative trial designs for emergency medicine

Katherine J Lee et al. Emerg Med Australas. 2025 Feb.

Abstract

Randomised trials have long been recognised as the gold standard research tool for evidence-based medicine. The past decade has seen the emergence of several innovative trial designs that are revolutionising how trials are conducted. These innovative designs enable more efficient, pragmatic trials that can address complex research questions which were previously not possible. In this paper, we provide an overview of the key innovative designs that are likely to be useful in the emergency medicine context, namely cluster crossover and stepped wedge designs, sequential multiple assignment randomised trial (SMART) designs, and platform trials. We describe the main features of each design, outline their pros and cons, and describe when they may or may not be useful. We also provide examples of these innovative designs in contexts that are relevant to emergency medicine.

Keywords: adaptive trial; cluster randomised; platform trial; randomised trial.

PubMed Disclaimer

Conflict of interest statement

None declared.

Figures

Figure 1
Figure 1
Schematic of innovative trial designs. (a) Cluster crossover trial with two intervention arms and two periods. (b) Stepped wedge trial with four clusters and five periods. (c) Sequential multiple assignment randomised trial with two stages, where non‐responders are re‐randomised to intervention or control. (d) Platform trial with three domains*. R, randomisation. *The platform starts with two domains. Domain 1 initially randomises participants between three arms. A new intervention (Intervention 3) is added to Domain 1 in Stage 2, and one intervention is stopped (Intervention 1) and another new intervention (Intervention 4) is added in Stage 3. Domain 2 randomises participants between two arms throughout the trial. A new domain (Domain 3) is added in Stage 2 and randomises participants between two arms until the end of the trial.

References

    1. Grimes DA, Schulz KF. An overview of clinical research: the lay of the land. Lancet 2002; 359: 57–61. - PubMed
    1. Donner A, Klar N, eds. Design and Analysis of Cluster Randomization Trials in Health Research. London: Arnold, 2000.
    1. Weijer C, Grimshaw JM, Taljaard M et al. Ethical issues posed by cluster randomized trials in health research. Trials 2011; 12: 100. - PMC - PubMed
    1. Eldridge S, Kerry S. A Practical Guide to Cluster Randomised Trials in Health Services Research. Chichester: Wiley, 2012.
    1. Hemming K, Girling AJ, Sitch AJ, Marsh J, Lilford RJ. Sample size calculations for cluster randomised controlled trials with a fixed number of clusters. BMC Med. Res. Methodol. 2011; 11: 102. - PMC - PubMed

MeSH terms

LinkOut - more resources